logo
  

Medtronic Guides Q4 Adj. EPS In Line With Estimates - Quick Facts

While reporting financial results for the third quarter on Tuesday, medical devices maker Medtronic plc. (MDT) provided its adjusted earnings and revenue growth guidance for the fourth quarter.

For the fourth quarter, the company now projects adjusted earnings in a range of $1.56 to $1.58 per share, which includes a neutral to slightly positive impact from foreign currency based on recent rates. The company also expects organic revenue growth of approximately 5.5 percent. Revenue would be negatively affected by approximately $185 million at current exchange rates

On average, analysts polled by Thomson Reuters expect the company to report earnings of $1.58 per share on revenue growth of 3.7 percent to $8.49 billion for the quarter. Analysts' estimates typically exclude special items.

"We are starting to see procedure volumes improve, and our outlook assumes continued recovery through March and April. By the time we exit the fourth quarter, we expect procedure volumes in most of our markets to be back to pre-COVID levels," said Karen Parkhill, Medtronic chief financial officer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Salt Lake City, Utah-based Creminelli Fine Meats is recalling around 4,207 pounds of ready-to-eat or RTE parmesan salami sticks citing misbranding and an undeclared allergen, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves 2.6-oz. plastic pouches containing "CREMINELLI FINE MEATS salami minis UNCURED ITALIAN SALAMI PARMESAN" with "BES The U.S. Food and Drug Administration is proposing a rule that will broaden the range of nonprescription or over-the counter drugs available to consumers. The rule titled, "Nonprescription Drug Product with an Additional Condition for Nonprescription Use," is intended to increase options for the development of safe and effective nonprescription drugs. The U.S. Food and Drug Administration announced that Australian organic infant formula and baby food producer, Bellamy's Organic, has agreed to send around 696,000 cans of general formula milk to the United States to meet the supply shortage. Under the FDA's enforcement discretion to source more infant formula to the U.S., the available Bellamy's Organic products include about 1.4 million pounds.
Follow RTT